Uncategorized

FDA authorizes marketing of Zika diagnostic test

Share

On May 23, the FDA authorized marketing of ZIKV Detect 2.0 IgM Capture ELISA, the first diagnostic test for detecting Zika virus immunoglobulin antibodies in human blood.

Read more at fda.gov.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

What is the primary purpose of a 3-minute foot assessment in patients with comorbidities such as diabetes or peripheral arterial disease?

Recent Posts